Answers are grounded in this paper and cite their sources.
Subjective cognitive decline (SCD) may be an early marker of Alzheimer's disease (AD) pathology. Until recently, it was impossible to measure biomarkers specific for α-synuclein pathology; therefore, its association with subjective reports of cognitive decline is unknown.
No takes yet. Share an insight, caveat, or question.
Thomas et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: